Chapter 5: Biological, Biochemical, and Genetic Basics

BACK . Book Description

Tetrahydrocannabinol, THC and Cannabidiol, CBD; Tolerance to THC; Common Genetics and Weed; DNA: The Long Stringy Stuff; Four Important Genes; Epigenetics; Cytochrome P450s: Cannabis, Prescription Drug interactions and Metabolism

Click on the link, PMID, or PMCID for any reference to go directly to the page, abstract or scientific paper. Use your browser FIND function (Ctrl F) to search for keywords.

Refs. 122-228

122. THC Wikipedia. Available from:

123. Hanus LO, Meyer SM, Munoz E, Taglialatela-Scafati O, Appendino G. Phytocannabinoids: a unified critical inventory. Nat Prod Rep. 2016;33(12):1357-92. PubMed PMID: 27722705

124. Sideli L, Trotta G, Spinazzola E, La Cascia C, Di Forti M. Adverse effects of heavy cannabis use: even plants can harm the brain. Pain. 2020. PubMed PMID: 32804835.

125. CBD Wikipedia. Available from:

126. Batalla A, Janssen H, Gangadin SS, Bossong MG. The Potential of Cannabidiol as a Treatment for Psychosis and Addiction: Who Benefits Most? A Systematic Review. J Clin Med. 2019;8(7). PubMed PMID: 31330972; PubMed Central PMCID: 6678854. FREE

127. Zeyl V, Sawyer K, Wightman RS. What Do You Know About Maryjane? A Systematic Review of the Current Data on the THC:CBD Ratio. Subst Use Misuse. 2020:1-5. PubMed PMID: 32124675. FREE

128. Cannabigerol Wikipedia [8/21-2020]. Available from:

129. Cannabis sativa Wikipedia [8/8/2020]. Available from:

130. Cannabis indica Wikipedia [8/8/2020]. Available from:

131. Morland J, Bramness JG. Delta9-tetrahydrocannabinol (THC) is present in the body between smoking sessions in occasional non-daily cannabis users. Forensic Sci Int. 2020;309:110188. PubMed PMID: 32120192.

132. Howlett AC, Abood ME. CB1 and CB2 Receptor Pharmacology. Adv Pharmacol. 2017;80:169-206. PubMed PMID: 28826534; PubMed Central PMCID: 5812699. FREE

133. CNR1 CB1 Entrez gene. Available from:

134. CNR2 CB2 Entrez gene. Available from:

135. CNRI Cannabinoid receptor IUPHAR/BPS Guide to Pharmacology [4/6/2020]. Available from:

136. Pava MJ, Makriyannis A, Lovinger DM. Endocannabinoid Signaling Regulates Sleep Stability. PLoS One. 2016;11(3):e0152473. PubMed PMID: 27031992; PubMed Central PMCID: 4816426. FREE

137. Dopamine Wikipedia. Available from:

138. Oleson EB, Cheer JF. A brain on cannabinoids: the role of dopamine release in reward seeking. Cold Spring Harb Perspect Med. 2012;2(8). PubMed PMID: 22908200; PubMed Central PMCID: 3405830. FREE

139. Anandamide Wikipedia. Available from:

140. Volkow ND, Wang GJ, Telang F, Fowler JS, Alexoff D, Logan J, et al. Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severity. Proc Natl Acad Sci U S A. 2014;111(30):E3149-56. PubMed PMID: 25024177; PubMed CentralPMCID: 4121778. FREE

141. van de Giessen E, Weinstein JJ, Cassidy CM, Haney M, Dong Z, Ghazzaoui R, et al. Deficits in striatal dopamine release in cannabis dependence. Mol Psychiatry. 2017;22(1):68-75. PubMed PMID: 27001613; PubMed Central PMCID: 5033654. FREE

142. Bloomfield MA, Ashok AH, Volkow ND, Howes OD. The effects of Delta(9)-tetrahydrocannabinol on the dopamine system. Nature. 2016;539(7629):369-77. PubMed PMID: 27853201; PubMed CentralPMCID: 5123717. FREE

143. Ramaekers JG, Mason NL, Theunissen EL. Blunted highs: Pharmacodynamic and behavioral models of cannabis tolerance. Eur Neuropsychopharmacol. 2020;36:191-205. PubMed PMID: 32014378.

144. Hall W, Degenhardt L. Adverse health effects of non-medical cannabis use. Lancet. 2009;374(9698):1383-91. PubMed PMID: 19837255.

145. Executive Functions Wikipedia. Available from:

146. Alcaro A, Huber R, Panksepp J. Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective. Brain Res Rev. 2007;56(2):283-321. PubMed PMID: 17905440; PubMed Central PMCID: 2238694. FREE

147. Volkow ND, Gillespie H, Mullani N, Tancredi L, Grant C, Valentine A, et al. Brain glucose metabolism in chronic marijuana users at baseline and during marijuana intoxication. Psychiatry Res. 1996;67(1):29-38. PubMed PMID: 8797240.

148. Peters KZ, Oleson EB, Cheer JF. A Brain on Cannabinoids: The Role of Dopamine Release in Reward Seeking and Addiction. Cold Spring Harb Perspect Med. 2020. PubMed PMID: 31964646.

149. Polli L, Schwan R, Albuisson E, Malbos L, Angioi-Duprez K, Laprevote V, et al. Oscillatory potentials abnormalities in regular cannabis users: Amacrine cells dysfunction as a marker of central dopaminergic modulation. Prog Neuropsychopharmacol Biol Psychiatry. 2020:110083. PubMed PMID: 32860840.

150. Chetia S, Borah G. Delta 9-Tetrahydrocannabinol Toxicity and Validation of Cannabidiol on Brain Dopamine Levels: An Assessment on Cannabis Duplicity. Nat Prod Bioprospect. 2020. PubMed PMID: 32860199.

151. Mesolimbic pathway -Wikipedia [8/31/2020]. Available from:

152. Bloomfield MA, Morgan CJ, Kapur S, Curran HV, Howes OD. The link between dopamine function and apathy in cannabis users: an [18F]-DOPA PET imaging study. Psychopharmacology (Berl). 2014;231(11):2251-9. PubMed PMID: 24696078.

153. Abood ME, Martin BR. Neurobiology of marijuana abuse. Trends Pharmacol Sci. 1992;13(5):201-6. PubMed PMID: 1604713.

154. Compton DR, Dewey WL, Martin BR. Cannabis dependence and tolerance production. Adv Alcohol Subst Abuse. 1990;9(1-2):129-47. PubMed PMID: 2165734.

155. Nowlan R, Cohen S. Tolerance to marijuana: heart rate and subjective “high”. Clin Pharmacol Ther. 1977;22(5 Pt 1):550-6. PubMed PMID: 913022.

156. Gregor Mendel Wikipedia [9/26/2020]. Available from:

157. Becker KG. The common variants/multiple disease hypothesis of common complex genetic disorders. Med Hypotheses. 2004;62(2):309-17. PubMed PMID: 14962646.

158. SNPedia Cannabis SNPS. Available from:

159. Gutleb DR, Roos C, Noll A, Ostner J, Schulke O. COMT Val(158) Met moderates the link between rank and aggression in a non-human primate. Genes Brain Behav. 2018;17(4):e12443. PubMed PMID: 29194954.

160. Quinn PD, Harden KP. Differential changes in impulsivity and sensation seeking and the escalation of substance use from adolescence to early adulthood. Dev Psychopathol. 2013;25(1):223-39. PubMed PMID: 22824055; PubMed Central PMCID: 3967723. FREE

161. Ehlers CL, Slutske WS, Lind PA, Wilhelmsen KC. Association between single nucleotide polymorphisms in the cannabinoid receptor gene (CNR1) and impulsivity in southwest California Indians. Twin Res Hum Genet. 2007;10(6):805-11. PubMed PMID: 18179391.

162. Colonna V, Pagani L, Xue Y, Tyler-Smith C. A world in a grain of sand: human history from genetic data. Genome Biol. 2011;12(11):234. PubMed PMID: 22104725; PubMed Central PMCID: 3334592. FREE

163. Jang SK, Saunders G, Liu M, andMe Research T, Jiang Y, Liu DJ, et al. Genetic correlation, pleiotropy, and causal associations between substance use and psychiatric disorder. Psychol Med. 2020:1-11. PubMed PMID: 32762793.

164. CNR1 3D SWISS MODEL [4-26-20]. Available from:

165. Hopfer CJ, Young SE, Purcell S, Crowley TJ, Stallings MC, Corley RP, et al. Cannabis receptor haplotype associated with fewer cannabis dependence symptoms in adolescents. Am J Med Genet B Neuropsychiatr Genet. 2006;141B(8):895-901. PubMed PMID: 16917946; PubMed Central PMCID: 2564870. FREE

166. CNR1 rs806368 SNPedia [4/6/20]. Available from:

167. Agrawal A, Wetherill L, Dick DM, Xuei X, Hinrichs A, Hesselbrock V, et al. Evidence for association between polymorphisms in the cannabinoid receptor 1 (CNR1) gene and cannabis dependence. Am J Med Genet B Neuropsychiatr Genet. 2009;150B(5):736-40. PubMed PMID: 19016476; PubMed Central PMCID: 2703788. FREE

168. Hill SY, Jones BL, Steinhauer SR, Zezza N, Stiffler S. Longitudinal predictors of cannabis use and dependence in offspring from families at ultra high risk for alcohol dependence and in control families. Am J Med Genet B Neuropsychiatr Genet. 2016;171B(3):383-95. PubMed PMID: 26756393; PubMed Central PMCID: 5444658. FREE

169. Schacht JP, Hutchison KE, Filbey FM. Associations between cannabinoid receptor-1 (CNR1) variation and hippocampus and amygdala volumes in heavy cannabis users. Neuropsychopharmacology. 2012;37(11):2368-76. PubMed PMID: 22669173; PubMed Central PMCID: 3442352. FREE

170. Marcos M, Pastor I, de la Calle C, Barrio-Real L, Laso FJ, Gonzalez-Sarmiento R. Cannabinoid receptor 1 gene is associated with alcohol dependence. Alcohol Clin Exp Res. 2012;36(2):267-71. PubMed PMID: 22085192.

171. Chen X, Williamson VS, An SS, Hettema JM, Aggen SH, Neale MC, et al. Cannabinoid receptor 1 gene association with nicotine dependence. Arch Gen Psychiatry. 2008;65(7):816-24. PubMed PMID: 18606954; PubMed Central PMCID: 2733353. FREE

172. Zuo L, Kranzler HR, Luo X, Yang BZ, Weiss R, Brady K, et al. Interaction between two independent CNR1 variants increases risk for cocaine dependence in European Americans: a replication study in family-based sample and population-based sample. Neuropsychopharmacology. 2009;34(6):1504-13. PubMed PMID: 19052543; PubMed Central PMCID: 2879626. FREE

173. Clarke TK, Bloch PJ, Ambrose-Lanci LM, Ferraro TN, Berrettini WH, Kampman KM, et al. Further evidence for association of polymorphisms in the CNR1 gene with cocaine addiction: confirmation in an independent sample and meta-analysis. Addict Biol. 2013;18(4):702-8. PubMed PMID: 21790903; PubMed CentralPMCID: 3223560. FREE

174. Jaeger JP, Mattevi VS, Callegari-Jacques SM, Hutz MH. Cannabinoid type-1 receptor gene polymorphisms are associated with central obesity in a Southern Brazilian population. Dis Markers. 2008;25(1):67-74. PubMed PMID: 18776593; PubMed Central PMCID: 3827795. FREE

175. Palmer, R.H.C, McGeary, J.E., Knopik, V.S., Bidwell, L.C., Metrik, J.M CNR1 and FAAH variation and affective states induced by marijuana smoking. Am J Drug Alcohol Abuse. 2019;45(5):514-526. PubMed PMID31184938 PubMed Central PMC6931041 FREE

176. Lu AT, Ogdie MN, Jarvelin MR, Moilanen IK, Loo SK, McCracken JT, et al. Association of the cannabinoid receptor gene (CNR1) with ADHD and post-traumatic stress disorder. Am J Med Genet B Neuropsychiatr Genet. 2008;147B(8):1488-94. PubMed PMID: 18213623; PubMed Central PMCID: 2685476. FREE

177. Herman AI, Kranzler HR, Cubells JF, Gelernter J, Covault J. Association study of the CNR1 gene exon 3 alternative promoter region polymorphisms and substance dependence. Am J Med Genet B Neuropsychiatr Genet. 2006;141B(5):499-503. PubMed PMID: 16741937; PubMed Central PMCID: 2574012. FREE

178. COMT 3D SWISS MODEL [4-26-20]. Available from:

179. Radhakrishnan R, Wilkinson ST, D’Souza DC. Gone to Pot – A Review of the Association between Cannabis and Psychosis. Front Psychiatry. 2014;5:54. PubMed PMID: 24904437; PubMed Central PMCID: 4033190. FREE

180. Tartar JL, Cabrera D, Knafo S, Thomas JD, Antonio J, Peacock CA. The “Warrior” COMT Val/Met Genotype Occurs in Greater Frequencies in Mixed Martial Arts Fighters Relative to Controls. J Sports Sci Med. 2020;19(1):38-42. PubMed PMID: 32132825; PubMed Central PMCID: 7039020. FREE

181. Caspi A, Moffitt TE, Cannon M, McClay J, Murray R, Harrington H, et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol Psychiatry. 2005;57(10):1117-27. PubMed PMID: 15866551.

182. Bosia M, Buonocore M, Bechi M, Stere LM, Silvestri MP, Inguscio E, et al. Schizophrenia, cannabis use and Catechol-O-Methyltransferase (COMT): Modeling the interplay on cognition. Prog Neuropsychopharmacol Biol Psychiatry. 2019;92:363-8. PubMed PMID: 30790675.

183. Lodhi RJ, Wang Y, Rossolatos D, MacIntyre G, Bowker A, Crocker C, et al. Investigation of the COMT Val158Met variant association with age of onset of psychosis, adjusting for cannabis use. Brain Behav. 2017;7(11):e00850. PubMed PMID: 29201551; PubMed Central PMCID: 5698868. FREE

184. Pearson NT, Berry JH. Cannabis and Psychosis Through the Lens of DSM-5. Int J Environ Res Public Health. 2019;16(21). PubMed PMID: 31661851; PubMed Central PMCID: 6861931. FREE

185. Cosker E, Schwitzer T, Ramoz N, Ligier F, Lalanne L, Gorwood P, et al. The effect of interactions between genetics and cannabis use on neurocognition. A review. Prog Neuropsychopharmacol Biol Psychiatry. 2018;82:95-106. PubMed PMID: 29191570.

186. COMT rs4680 SNPedia [4-11-20]. Available from:

187. DRD2 Entrez Gene [2-26-20]. Available from:

188. DRD2 3D structure SWISS MODEL [4-26-20]. Available from:

189. Bhatia A, Saadabadi A. Biochemistry, Dopamine Receptors. StatPearls. Treasure Island (FL)2020.

190. Dopamine receptors Wikipedia [4-26-20]. Available from:

191. Lopez-Morales P, Flores-Funes D, Sanchez-Migallon EG, Liron-Ruiz RJ, Aguayo-Albasini JL. Genetic Factors Associated with Postoperative Nausea and Vomiting: a Systematic Review. J Gastrointest Surg. 2018;22(9):1645-51. PubMed PMID: 29725907.

192. Agrawal A, Lynskey MT. Candidate genes for cannabis use disorders: findings, challenges and directions. Addiction. 2009;104(4):518-32. PubMed PMID: 19335651; PubMed Central PMCID: 2703791. FREE

193. Colizzi M, Iyegbe C, Powell J, Ursini G, Porcelli A, Bonvino A, et al. Interaction Between Functional Genetic Variation of DRD2 and Cannabis Use on Risk of Psychosis. Schizophr Bull. 2015;41(5):1171-82. PubMed PMID: 25829376; PubMed Central PMCID: 4535639. FREE

194. Sasabe T, Furukawa A, Matsusita S, Higuchi S, Ishiura S. Association analysis of the dopamine receptor D2 (DRD2) SNP rs1076560 in alcoholic patients. Neurosci Lett. 2007;412(2):139-42. PubMed PMID: 17196743.

195. DRD2 SNP Rs1076560 SNPedia [4-26-20]. Available from:

196. Klaus K, Butler K, Curtis F, Bridle C, Pennington K. The effect of ANKK1 Taq1A and DRD2 C957T polymorphisms on executive function: A systematic review and meta-analysis. Neurosci Biobehav Rev. 2019;100:224-36. PubMed PMID: 30836122.

197. Klaus K, Butler K, Durrant SJ, Ali M, Inglehearn CF, Hodgson TL, et al. The effect of COMT Val158Met and DRD2 C957T polymorphisms on executive function and the impact of early life stress. Brain Behav. 2017;7(5):e00695. PubMed PMID: 28523234; PubMed Central PMCID: 5434197. FREE

198. Rodriguez-Jimenez R, Hoenicka J, Jimenez-Arriero MA, Ponce G, Bagney A, Aragues M, et al. Performance in the Wisconsin Card Sorting Test and the C957T polymorphism of the DRD2 gene in healthy volunteers. Neuropsychobiology. 2006;54(3):166-70. PubMed PMID: 17230034.

199. Liu L, Fan D, Ding N, Hu Y, Cai G, Wang L, et al. The relationship between DRD2 gene polymorphisms (C957T and C939T) and schizophrenia: a meta-analysis. Neurosci Lett. 2014;583:43-8. PubMed PMID: 25240594.

200. Jutras-Aswad D, Jacobs MM, Yiannoulos G, Roussos P, Bitsios P, Nomura Y, et al. Cannabis-dependence risk relates to synergism between neuroticism and proenkephalin SNPs associated with amygdala gene expression: case-control study. PLoS One. 2012;7(6):e39243. PubMed PMID: 22745721; PubMed Central PMCID: 3382183. FREE

201. DRD2 rs6277 SNPedia [4-26-20]. Available from:

202. FAAH Wikipedia

203. Ahn K, Johnson DS, Cravatt BF. Fatty acid amide hydrolase as a potential therapeutic target for the treatment of pain and CNS disorders. Expert Opin Drug Discov. 2009;4(7):763-84. PubMed PMID: 20544003; PubMed Central PMCID: 2882713. FREE

204. Habib AM, Okorokov AL, Hill MN, Bras JT, Lee MC, Li S, et al. Microdeletion in a FAAH pseudogene identified in a patient with high anandamide concentrations and pain insensitivity. Br J Anaesth. 2019;123(2):e249-e53. PubMed PMID: 30929760; PubMed Central PMCID: 6676009. FREE

205. Sipe J.C., Chiang K., Gerber A.L., Beutler E., and Cravatt B.F. A missense mutation in human fatty acid amide hydrolase associated with problem drug use. Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):8394-9. PubMed PMID12060782 PubMed Central PMC123078 FREE

206. Melroy-Greif WE, Wilhelmsen KC, Ehlers CL. Genetic variation in FAAH is associated with cannabis use disorders in a young adult sample of Mexican Americans. Drug Alcohol Depend. 2016;166:249-53. PubMed PMID: 27394933; PubMed Central PMCID: 4983484. FREE

207. Jacobson MR, Watts JJ, Da Silva T, Tyndale RF, Rusjan PM, Houle S, et al. Fatty acid amide hydrolase is lower in young cannabis users. Addict Biol. 2020:e12872. PubMed PMID: 31960544.

208. D’Souza DC, Cortes-Briones J, Creatura G, Bluez G, Thurnauer H, Deaso E, et al. Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-controlled, parallel group, phase 2a single-site randomised controlled trial. Lancet Psychiatry. 2019;6(1):35-45. PubMed PMID: 30528676.

209. Haughey HM, Marshall E, Schacht JP, Louis A, Hutchison KE. Marijuana withdrawal and craving: influence of the cannabinoid receptor 1 (CNR1) and fatty acid amide hydrolase (FAAH) genes. Addiction. 2008;103(10):1678-86. PubMed PMID: 18705688; PubMed Central PMCID: 2873690. FREE

210. Filbey FM, Schacht JP, Myers US, Chavez RS, Hutchison KE. Individual and additive effects of the CNR1 and FAAH genes on brain response to marijuana cues. Neuropsychopharmacology. 2010;35(4):967-75. PubMed PMID: 20010552; PubMed Central PMCID: 2820137. FREE

211. Schacht JP, Selling RE, Hutchison KE. Intermediate cannabis dependence phenotypes and the FAAH C385A variant: an exploratory analysis. Psychopharmacology (Berl). 2009;203(3):511-7. PubMed PMID: 19002671; PubMed Central PMCID: 2863054. FREE

212. Campos AC, Moreira FA, Gomes FV, Del Bel EA, Guimaraes FS. Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders. Philos Trans R Soc Lond B Biol Sci. 2012;367(1607):3364-78. Epub 2012/10/31. doi: 10.1098/rstb.2011.0389. PubMed PMID: 23108553; PubMed Central PMCID: 3481531 FREE

213. Gunduz-Cinar O, Hill MN, McEwen BS, Holmes A. Amygdala FAAH and anandamide: mediating protection and recovery from stress. Trends Pharmacol Sci. 2013;34(11):637-44. Epub 2013/12/12. doi: 10.1016/ PubMed PMID: 24325918; PubMed Central PMCID: 4169112. FREE

214. FAAH rs324420 SNPedia [4-11-20]. Available from:

215. Hindocha C, Quattrone D, Freeman TP, Murray RM, Mondelli V, Breen G, et al. Do AKT1, COMT and FAAH influence reports of acute cannabis intoxication experiences in patients with first episode psychosis, controls and young adult cannabis users? Transl Psychiatry. 2020;10(1):143. PubMed PMID: 32398646.

216. Di Forti M, Iyegbe C, Sallis H, Kolliakou A, Falcone MA, Paparelli A, et al. Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users. Biol Psychiatry. 2012;72(10):811-6. PubMed PMID: 22831980.

217. Szutorisz H, Hurd YL. High times for cannabis: Epigenetic imprint and its legacy on brain and behavior. Neurosci Biobehav Rev. 2018;85:93-101. PubMed PMID: 28506926; PubMed Central PMCID: 5682234. FREE

218. Osborne AJ, Pearson JF, Noble AJ, Gemmell NJ, Horwood LJ, Boden JM, et al. Genome-wide DNA methylation analysis of heavy cannabis exposure in a New Zealand longitudinal cohort. Transl Psychiatry. 2020;10(1):114. PubMed PMID: 32321915; PubMed Central PMCID: 7176736. FREE

219. Epigenetics Wikkipedia Access date 1-11-2021

220. Prini P, Rusconi F, Zamberletti E, Gabaglio M, Penna F, Fasano M, et al. Adolescent THC exposure in female rats leads to cognitive deficits through a mechanism involving chromatin modifications in the prefrontal cortex. J Psychiatry Neurosci. 2017;42(6):170082. PubMed PMID: 29022873.

221. Wanner, N.M., Colwell, M.L., and Faulk C. The epigenetic legacy of illicit drugs: developmental exposures and late-life phenotypes. Environ Epigenet. 2019 Nov 13;5(4) PubMed PMID31777665 PubMed Central PMC6875650 FREE

222. Smith, A., Kaufman, F., Sandy, M.S., Cardenas, A. Cannabis Exposure During Critical Windows of Development: Epigenetic and Molecular Pathways Implicated in Neuropsychiatric Disease. Curr Environ Health Rep. 2020 Sep;7(3):325-342. PubMed PMID32441004 PubMed Central PMC7458902 FREE

223. Cytochrome P450 Wikipedia [9/14/2020]. Available from:

224. Stout SM, Cimino NM. Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review. Drug Metab Rev. 2014;46(1):86-95. PubMed PMID: 24160757. FREE

225. Watanabe K, Yamaori S, Funahashi T, Kimura T, Yamamoto I. Cytochrome P450 enzymes involved in the metabolism of tetrahydrocannabinols and cannabinol by human hepatic microsomes. Life Sci. 2007;80(15):1415-9. PubMed PMID: 17303175.

226. Medical Cannabis Adverse Effects & Drug Interactions District of Columbia Dept of Health [9/14/2020]. Available from: District of Columbia Dept of Health

227. Damkier P, Lassen D, Christensen MMH, Madsen KG, Hellfritzsch M, Pottegard A. Interaction between warfarin and cannabis. Basic Clin Pharmacol Toxicol. 2019;124(1):28-31. PubMed PMID: 30326170.

228. Cox EJ, Maharao N, Patilea-Vrana G, Unadkat JD, Rettie AE, McCune JS, et al. A marijuana-drug interaction primer: Precipitants, pharmacology, and pharmacokinetics. Pharmacol Ther. 2019;201:25-38. PubMed PMID: 31071346; PubMed Central PMCID: 6708768. FREE

Click here for the book:

%d bloggers like this: